Skip to content
New: Acetyl-L-Carnitine Benefits: The Real Evidence

Supplements

NAD+, NR, and NMN: The Cellular Energy Currency

MitoHacker·Updated July 8, 2026·2 min read
Share:

Community Consensus

Do you like NR (Nicotinamide Riboside)?

Reflects reader sentiment, not medical advice or a recommendation.

Community Consensus

Do you like NMN?

Reflects reader sentiment, not medical advice or a recommendation.

Community Consensus

Do you like NAD+?

Reflects reader sentiment, not medical advice or a recommendation.

Quick answer

NAD+ is a coenzyme central to energy metabolism that declines with age. Precursors like NR and NMN reliably raise NAD+ levels in humans, and that part is well established. Whether higher NAD+ produces meaningful benefits in healthy people (energy, metabolic health, longevity) is still uncertain and actively researched.

Key takeaways

  • NAD+ is an electron carrier essential for ATP production and a substrate for DNA repair and sirtuin signaling.
  • NAD+ levels fall with age, which is why it became a longevity research target.
  • Oral NAD+ is poorly absorbed, liposomal delivery is unclear, and IV and SubQ are well-researched routes; people use precursors (NR, NMN) mainly for convenient oral dosing.
  • Trials consistently show NR and NMN raise NAD+; clinical benefits in healthy people are mixed and unsettled.
  • NMN's status as a US dietary supplement has been contested, which is a legal issue, not necessarily a safety one.

Why NAD+ matters

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell and central to energy metabolism. It acts as an electron carrier, ferrying electrons into the mitochondria to drive ATP production, and it is a required substrate for enzymes involved in DNA repair and cellular signaling (including the sirtuins, a family of proteins linked to healthy aging).

Here’s the catch: NAD+ levels decline with age. That decline is one reason NAD+ became a focal point of longevity research. Restore the coenzyme, the thinking goes, and you may support the processes that depend on it.

The precursors: NR and NMN

How you get NAD+ into the body is the part most people get wrong. Taken orally, NAD+ itself is poorly absorbed, so swallowing it isn’t an effective route. Liposomal oral delivery is being researched as a workaround, but the evidence there remains unclear. Injected forms are a different story: IV (intravenous) and SubQ (subcutaneous) NAD+ are well-researched, established routes of administration. So the reason most people reach for precursors isn’t that NAD+ can’t be administered. It’s that precursors give you convenient oral dosing. Your cells then convert them into NAD+:

  • NR (nicotinamide riboside): the most clinically studied precursor, with several human trials.
  • NMN (nicotinamide mononucleotide): one step closer to NAD+ in the pathway. Increasingly studied, though its regulatory status as a supplement has been contested in the United States.

What the evidence shows, and where it’s uncertain

Here the honesty matters. Human trials consistently show that NR and NMN reliably raise NAD+ levels in the blood and tissues. That part is well established. What is far less settled is whether raising NAD+ produces meaningful clinical benefits in healthy people: more energy, better metabolic health, slower aging. Results so far are mixed. Some studies show improvements in specific measures (for example, insulin sensitivity in certain populations), while others show biochemical changes without a clear functional payoff.

NAD+ precursors do what they say at the biochemistry level. Whether that translates into how you feel or how you age is an open, actively researched question.

A note on NMN’s status

NMN’s availability as a dietary supplement has been the subject of regulatory dispute in the US. This is a shifting legal landscape, not a comment on safety per se, but it is worth being aware of when sourcing.

How to think about it

NAD+ precursors are among the most hyped longevity supplements, and the biochemistry is real. But hype has run ahead of the outcome data. If you try them, do so with realistic expectations. And remember that exercise also raises NAD+ and improves the very outcomes these supplements are marketed for. Educational information only, not medical advice.

Frequently asked questions

What is the difference between NR and NMN?

Both are precursors the body converts into NAD+. NR (nicotinamide riboside) is the most clinically studied. NMN (nicotinamide mononucleotide) is one step closer to NAD+ in the pathway and increasingly studied, though its regulatory status as a US supplement has been disputed.

Do NAD+ supplements actually work?

They reliably raise NAD+ levels, and that is well established. Whether that translates into more energy, better metabolic health, or slower aging in healthy people is uncertain, since human outcome data are mixed. Set expectations accordingly.

Can I raise NAD+ without supplements?

Yes. Exercise and metabolic stressors naturally increase NAD+ turnover and improve many of the same outcomes NAD+ supplements are marketed for, often more reliably than the supplements themselves.

Why do people take precursors instead of NAD+ itself?

Mostly for convenient oral dosing. Oral NAD+ is poorly absorbed, and liposomal oral delivery is still being researched with unclear evidence. IV and SubQ NAD+ are well-researched routes, but precursors like NR and NMN let you dose by mouth, and your cells convert them into NAD+.

Is NMN legal and safe?

NMN's availability as a US dietary supplement has been the subject of regulatory dispute, which is a shifting legal matter rather than a direct safety verdict. Short-term human studies suggest good tolerability. This is educational information, not medical or legal advice.

References

  1. 1.Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547.
  2. 2.Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286.
  3. 3.Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229.
  4. 4.Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.

Keep reading

Supplements

Acetyl-L-Carnitine Benefits: The Real Evidence

Acetyl-L-carnitine, sold as ALCAR, is L-carnitine with an acetyl group attached, and that single modification is why it exists as a separate product: it crosses the blood-brain barrier more readily than plain L-carnitine. The strongest human evidence is in peripheral neuropathy and depressive symptoms. Two 52-week randomised placebo-controlled trials in 1,257 patients with diabetic neuropathy found improved sural nerve fibre numbers, regenerating fibre clusters, pain and vibratory perception at 1,000 mg three times daily, with more benefit in patients treated earlier. A meta-analysis of 12 trials in 791 participants found reduced depressive symptoms, comparable to standard antidepressants with fewer side effects. It is weakest at the two things it is most often sold for. The dementia trials did not deliver despite a strong acetylcholine mechanism, and a Cochrane review found insufficient evidence to recommend it. Most importantly, in 409 women receiving taxane chemotherapy, 3,000 mg/day of ALCAR made neuropathy significantly worse than placebo, and the effect was still present at 104 weeks. That result means ALCAR should be treated as a compound with specific indications, not a general nerve or brain supplement.

Read →

Supplements

L-Carnitine Side Effects: What Actually Happens

At ordinary supplement doses most people tolerate L-carnitine well. The side effects that do appear are dose-dependent: nausea, abdominal cramping and diarrhoea, plus a fishy body, breath and urine odour that surprises people because it is not an allergy or a bad batch. Gut bacteria convert unabsorbed carnitine into trimethylamine, which smells like rotting fish and leaves the body through sweat and breath, so a shower does not fix it. It is dose-related and fully reverses on stopping. A published risk assessment put the observed safe level at 2,000 mg per day. Four situations deserve real caution rather than a shrug: an existing seizure disorder, thyroid treatment, warfarin, and impaired kidney function. L-carnitine acts as a peripheral antagonist of thyroid hormone, which is why it works against levothyroxine treatment. One question is genuinely unresolved: gut bacteria convert carnitine to TMAO, which accelerated atherosclerosis in mice, while pooled human trials in cardiac patients found lower mortality. Both findings stand. Unusually for a supplement, the certificate of analysis that matters most here confirms isomeric identity rather than potency, because the D-isomer competitively interferes with L-carnitine transport.

Read →

Supplements

How Much Alpha-Lipoic Acid Per Day, and When to Take It

The reference figure is 600 mg per day, and it comes from SYDNEY 2, a trial that compared 600, 1,200 and 1,800 mg of oral alpha-lipoic acid head to head. All three doses improved symptom scores by almost exactly the same amount, roughly 48 to 52 percent against 32 percent on placebo, while nausea, vomiting and vertigo rose steadily with dose. The authors concluded 600 mg once daily gave the best risk-to-benefit ratio, which is why nearly every capsule sold holds that amount. On timing, take it on an empty stomach, about 30 minutes before a meal or two hours after: food both delays and reduces absorption, and alpha-lipoic acid already starts from only about 30 percent absolute bioavailability because the liver extracts most of a dose on first pass. The hour of day matters far less than being fasted, which is the real reason bedtime dosing is popular. Two caveats matter. Those trials studied people with diabetic polyneuropathy, so applying the number to general wellness use is an extrapolation, and the four-year NATHAN 1 trial at 600 mg daily missed its primary endpoint.

Read →